A Professional & Personal Networking Site for Cardiologists Worldwide
We're sorry, but this discussion has just been closed to further replies.
Design Population based case-control study.
Setting Group Health Cooperative, Seattle, WA, USA.
Participants Cases (n=353) were aged 30-79 years, had pharmacologically treated hypertension, and were diagnosed with a first fatal or non-fatal myocardial infarction or stroke between 1989 and 2005. Controls (n=952) were a random sample of Group Health members who had pharmacologically treated hypertension. We excluded individuals with heart failure, evidence of coronary heart disease, diabetes, or chronic kidney disease.
Exposures One of three common two drug combinations: diuretics plus β blockers; diuretics plus calcium channel blockers; and diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Main outcome measures Myocardial infarction or stroke.
Results Compared with users of diuretics plus β blockers, users of diuretics plus calcium channel blockers had an increased risk of myocardial infarction (adjusted odds ratio (OR) 1.98, 95% confidence interval 1.37 to 2.87) but not of stroke (OR 1.02, 95% CI 0.63 to 1.64). The risks of myocardial infarction and stroke in users of diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers were slightly but not significantly lower than in users of diuretics plus β blockers (myocardial infarction: OR 0.76, 95% CI 0.52 to 1.11; stroke: OR 0.71, 95% CI 0.46 to 1.10).
Tags:
Impairment in Function and Expression of Transient Receptor Potential Vanilloid Type 4 in Dahl Salt-
Emergence of Ethnic Differences in Blood Pressure in Adolescence: The Determinants of Adolescent Soc
Incremental Predictive Value of Adding Past Blood Pressure Measurements to the Framingham Hypertensi
Estradiol-17{beta} and Its Cytochrome P450- and Catechol-O-Methyltransferase-Derived Metabolites Sti
© 2010 Created by Cardiology Rounds Team